Medical need, scientific opportunity and the drive for antimalarial drugs.
Continued and sustainable improvements in antimalarial medicines through focused research and development are essential for the world's future ability to treat and control malaria. Unfortunately, malaria is a disease of poverty, and despite a wealth of scientific knowledge there is insufficient market incentive to generate the competitive, business-driven industrial antimalarial drug research and development that is normally needed to deliver new products. Mechanisms of partnering with industry have been established to overcome this obstacle and to open up and build on scientific opportunities for improved chemotherapy in the future.
Ridley
Robert G
RG
Medicines fr Malaria Venture, Geneva, Switzerland. ridleyr@mmv.org
D000818:Animals; D000962:Antimalarials / Q000494:pharmacology / Q000627:therapeutic use; D006297:Health Services Accessibility; D006801:Humans; D020380:Needs Assessment; D010961:Plasmodium / Q000187:drug effects; D012106:Research
D000962:Antimalarials